2010
DOI: 10.1111/j.1468-3083.2010.03877.x
|View full text |Cite
|
Sign up to set email alerts
|

Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response

Abstract: Optimization of PDT procedure for BCC requires a careful selection of the lesions. In particular, superficial BCCs, preferentially located on the trunk, show the best therapeutic response.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
73
3
14

Year Published

2012
2012
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 99 publications
(93 citation statements)
references
References 26 publications
(78 reference statements)
3
73
3
14
Order By: Relevance
“…This fact was already noted in another large retrospective study [9] where a complete response rate of 82% was found for sBCC and 33% for nBCC ( P < 0.000). Together these findings suggest that nBCC is not a good indication for PDT and, as recommended in their treatment guidelines, and surgery continues to be the gold standard for treatment [8].…”
Section: Discussionsupporting
confidence: 75%
See 1 more Smart Citation
“…This fact was already noted in another large retrospective study [9] where a complete response rate of 82% was found for sBCC and 33% for nBCC ( P < 0.000). Together these findings suggest that nBCC is not a good indication for PDT and, as recommended in their treatment guidelines, and surgery continues to be the gold standard for treatment [8].…”
Section: Discussionsupporting
confidence: 75%
“…The level of recommendation in sBCC treatment guidelines is A with a level of evidence of I and B for nBCC with a level of evidence of I (surgery continues to be the gold standard for nBCC) [8]. However, since its approval, few large retrospective studies that study the results of its daily use and on fluorescence diagnosis have been published [911]. These studies, though having less statistical power than the clinical trials, reveal new aspects of PDT on BCC by describing what happens in routine clinical practice.…”
Section: Introductionmentioning
confidence: 99%
“…A few previous PDT studies have reported on tumor thickness as a histologic determinant of treatment failure in BCC. [8][9][10][11][12] However, results were contradictory, possibly because of the fact that inclusion was not restricted to sBCC subtypes. Only 1 study focused solely on sBCC and showed that after treatment with imiquimod a tumor with a thickness more than 0.4 mm was significantly more likely to reoccur than a thinner tumor.…”
mentioning
confidence: 79%
“…Studies of PDT have noted lower response rates and higher rates of treatment failure in thicker BCCs (> 0Á5 mm to > 2 mm). [29][30][31][32][33] A commonly cited cut-off is 1 mm. 30,33 One such study specifically noted response more closely associated with depth than subtype.…”
Section: Discussionmentioning
confidence: 99%